Zobrazeno 1 - 3
of 3
pro vyhledávání: '"T. V. Rubanik"'
Autor:
A. G. Chuchalin, P. K. Yablonskiy, T. V. Rubanik, O. A. Chernyavskaya, V. V. Naumov, L. I. Korneva, L. M. Kudelуa, A. Yu. Petukhova, O. V. Masalkina, Yu. V. Argamakova, G. L. Ignatova, A. G. Borisov, T. R. Kasyanova, A. K. Suleymanova
Publikováno v:
PULMONOLOGIYA. 33:52-63
Post-COVID syndrome develops after COVID-19 (COronaVIrus Disease 2019) and leads to cumulative effects in the form of shortness of breath and impaired lung function. Notably, patients with airway inflammation and COVID-19 were found to have increased
Comparative Study cf Biosimilar Genolar® Clinical Efficacy оп the Randomized Phase III Study Results
Autor:
D. V. Petrov, G. L. Osipova, V. N. Zorin, N. E. Kostina, N. A. Kuzubova, T. V. Rubanik, N. I. Il'ina, A. V. Averyanov, L. M. Kudelya, A. O. Molotkov, Sergey Avdeev, N. M. Nenasheva
Publikováno v:
PULMONOLOGIYA. 30:782-796
There are results of a comparative phase III clinical study on the efficiency and safety of the biosimilar drug Genolar® (Generium JSC, Russia) and the reference drug Xolair® (Novartis Pharma AG, Switzerland) ((NCT04607629). The study is aimed to e
Autor:
N. L. Shaporova, O. A. Aleshina, T. V. Rubanik, O. I. Krasnoshekova, V. I. Trophimov, I. Yu. Kroshkina, G. R. Sergeeva
Publikováno v:
PULMONOLOGIYA. :73-77
The aim of this study was to analyze the rationality of antibiotics administration and choice in patients with different respiratory diseases referred from outpatient departments to the city diagnostic center № 1 at Saint Petersburg. Two hundred an